Form 8-K - Current report:
SEC Accession No. 0001104659-19-024305
Filing Date
2019-04-29
Accepted
2019-04-29 09:02:47
Documents
3
Period of Report
2019-04-25
Items
Item 1.03: Bankruptcy or Receivership
Item 3.03: Material Modifications to Rights of Security Holders
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-8985_18k.htm 8-K 36173
2 EX-99.1 a19-8985_1ex99d1.htm EX-99.1 976447
3 GRAPHIC g89851mm29i001.jpg GRAPHIC 24926
  Complete submission text file 0001104659-19-024305.txt   1048564
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35268 | Film No.: 19773949
SIC: 2834 Pharmaceutical Preparations